Kura Oncology,Inc.(纳斯达克市场代码:KURA)是一家致力于实现治疗癌症的精确药物承诺的临床阶段生物制药公司,该公司今天宣布在《柳叶刀肿瘤学》杂志上发表其KOMET-001第一阶段研究手稿。这篇题为“Ziftomenib治疗复发性/难治性急性髓系白血病(KOMET-001):来自开放标签、多队列、1a/1b期试验的结果”的论文现可在《柳...
该公司公布了KOMET-001的总体结果。
【用于急性髓系白血病!突破性小分子疗法达到临床主要终点】北京时间2025你那2月6日,Kura Oncology与Kyowa Kirin宣布,在研疗法ziftomenib在治疗复发/难治性(R/R)NPM1突变(NPM1-m)急性髓系白血病(AML)患者的注册性2期临床试验KOMET-001中取得积极的顶线结果。同时,Kura正按计划于2025年第二季度向美国FDA提交zifto...
Methods KOMET-001 is a multicentre, open-label, multi-cohort, phase 1/2 clinical trial of ziftomenib in adults with relapsed or refractory acute myeloid leukaemia. Results of the phase 1 study, conducted at 22 hospitals in France, Italy, Spain, and the USA, are presented here and comprise...
Clients Become a member to see clients information. Try IMDbPro Premium for free Affiliations Become a member to see affiliations information. Try IMDbPro Premium for free Trending Become a member to see COMPANYmeter for Komet-Film-Compagnie. ...
tgl 16 Okt sekitar pkl 10.00, terlihat s'buah komet berwarna kuning, agak kecil aja sich. Apa di antara anggota JAC ada yg ngeliat juga ? Kira2 namanya komet apa yach? k'lo ada yg tau , kasihtau aq ya ! ___ Apakah Anda Yahoo!? Lelah menerima spam? Surat Yahoo! memiliki perlind...